⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for recurrent uterine sarcoma

Every month we try and update this database with for recurrent uterine sarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study titleNCT IDConditionsInterventionsEligibilityOrganizationLink
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaNCT00390234
Fallopian Tube ...
Female Reproduc...
Ovarian Carcino...
Ovarian Sarcoma
Recurrent Ovari...
Recurrent Uteri...
Stage III Ovari...
Stage III Uteri...
Stage IV Ovaria...
Stage IV Uterin...
Uterine Carcino...
Uterine Leiomyo...
ziv-aflibercept
18 Years - National Cancer Institute (NCI)
Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersNCT01846520
Healthy Subject
Localized Trans...
Metastatic Tran...
Psychosocial Ef...
Recurrent Bladd...
Recurrent Cervi...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Renal...
Recurrent Trans...
Recurrent Ureth...
Recurrent Uteri...
Regional Transi...
Stage II Bladde...
Stage II Renal ...
Stage II Urethr...
Stage IIA Cervi...
Stage IIA Colon...
Stage IIA Gastr...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Pancr...
Stage IIA Recta...
Stage IIA Uteri...
Stage IIB Cervi...
Stage IIB Colon...
Stage IIB Gastr...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Pancr...
Stage IIB Recta...
Stage IIB Uteri...
Stage IIC Colon...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Recta...
Stage III Bladd...
Stage III Pancr...
Stage III Renal...
Stage III Ureth...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Rect...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Rect...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Rect...
Stage IIIC Uter...
Stage IV Bladde...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Renal ...
Stage IV Urethr...
Stage IVA Cervi...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Colon...
Stage IVB Recta...
Stage IVB Uteri...
Ureter Cancer
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
educational int...
telephone-based...
quality-of-life...
questionnaire a...
18 Years - City of Hope Medical Center
Chemotherapy in Treating Patients With Sarcoma of the UterusNCT00005643
Endometrial Can...
Sarcoma
pegylated lipos...
21 Years - GOG Foundation
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaNCT00002764
Endometrial Can...
Kidney Cancer
Metastatic Canc...
Ovarian Cancer
Pheochromocytom...
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
conventional su...
16 Years - European Organisation for Research and Treatment of Cancer - EORTC
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By SurgeryNCT01553539
Bone Cancer
Chondrosarcoma
Clear Cell Sarc...
Metastatic Oste...
Ovarian Sarcoma
Recurrent Adult...
Recurrent Osteo...
Recurrent Uteri...
Stage III Adult...
Stage III Uteri...
Stage IV Adult ...
Stage IV Uterin...
therapeutic ang...
laboratory biom...
18 Years - Wake Forest University Health Sciences
Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic CancerNCT00287885
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Peritoneal Cavi...
Sarcoma
Vaginal Cancer
Vulvar Cancer
docetaxel
18 Years - Masonic Cancer Center, University of Minnesota
Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the UterusNCT00003316
Sarcoma
gemcitabine hyd...
18 Years - GOG Foundation
STI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaNCT00006357
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
imatinib mesyla...
15 Years - European Organisation for Research and Treatment of Cancer - EORTC
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine CancerNCT00112489
Sarcoma
carboplatin
paclitaxel
18 Years - 120 YearsGOG Foundation
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaNCT00082823
Cancer
ziv-aflibercept
18 Years - 120 YearsRegeneron Pharmaceuticals
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaNCT00004066
Ovarian Cancer
Sarcoma
Small Intestine...
filgrastim
docetaxel
gemcitabine hyd...
18 Years - Memorial Sloan Kettering Cancer Center
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainNCT00550654
Kidney Cancer
Melanoma (Skin)
Metastatic Canc...
Ovarian Cancer
Sarcoma
Unspecified Adu...
questionnaire a...
3-dimensional c...
hypofractionate...
image-guided ra...
tomotherapy
18 Years - National Institutes of Health Clinical Center (CC)
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityNCT00003548
Cancer
aminocamptothec...
18 Years - NYU Langone Health
Perifosine in Treating Patients With Metastatic or Locally Advanced Soft Tissue SarcomaNCT00053794
Endometrial Can...
Sarcoma
perifosine
18 Years - 120 YearsCanadian Cancer Trials Group
T-Cell Response in Patients Receiving Trastuzumab and/or Chemotherapy for HER2-Positive Solid TumorsNCT00433407
Breast Cancer
Lung Cancer
Ovarian Cancer
Prostate Cancer
Sarcoma
Unspecified Adu...
trastuzumab
- Jonsson Comprehensive Cancer Center
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the UterusNCT00003128
Sarcoma
filgrastim
ifosfamide
paclitaxel
18 Years - GOG Foundation
Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the UterusNCT00003128
Sarcoma
filgrastim
ifosfamide
paclitaxel
18 Years - GOG Foundation
Chemotherapy in Treating Patients With Advanced SarcomaNCT00002526
Ovarian Cancer
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
18 Years - 70 YearsSwiss Group for Clinical Cancer Research
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Topotecan in Treating Patients With Recurrent or Refractory Cancer of the UterusNCT00003156
Sarcoma
topotecan hydro...
- GOG Foundation
Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the UterusNCT00002993
Sarcoma
cisplatin
doxorubicin hyd...
mitomycin C
- GOG Foundation
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerNCT01764789
Anxiety Disorde...
Depression
Fatigue
Leydig Cell Tum...
Ovarian Sarcoma
Ovarian Stromal...
Pain
Peritoneal Carc...
Pseudomyxoma Pe...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Gesta...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Recurrent Uteri...
Recurrent Vagin...
Recurrent Vulva...
questionnaire a...
quality-of-life...
psychosocial as...
behavioral inte...
cognitive inter...
educational int...
21 Years - 85 YearsOhio State University Comprehensive Cancer Center
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsNCT01155258
Extensive Stage...
Hereditary Para...
Male Breast Can...
Malignant Parag...
Metastatic Gast...
Metastatic Pheo...
Pancreatic Poly...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Gastr...
Recurrent Islet...
Recurrent Neuro...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pheoc...
Recurrent Prost...
Recurrent Renal...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Regional Pheoch...
Stage III Cervi...
Stage III Endom...
Stage III Neuro...
Stage III Ovari...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Endome...
Stage IV Neuroe...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Thyroid Gland M...
temsirolimus
vinorelbine dit...
18 Years - University of Southern California
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerNCT00003704
Cancer
capecitabine
radiation thera...
18 Years - Alliance for Clinical Trials in Oncology
Trabectedin in Treating Patients With Advanced, Persistent, or Recurrent Leiomyosarcoma of the UterusNCT00379145
Sarcoma
trabectedin
18 Years - 120 YearsGOG Foundation
EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerNCT00087191
Advanced Adult ...
Carcinoma of th...
Fallopian Tube ...
Gastrointestina...
Localized Extra...
Localized Gallb...
Localized Gastr...
Localized Resec...
Localized Unres...
Metastatic Gast...
Ovarian Sarcoma
Ovarian Stromal...
Primary Periton...
Recurrent Adult...
Recurrent Adult...
Recurrent Colon...
Recurrent Extra...
Recurrent Gallb...
Recurrent Gastr...
Recurrent Gastr...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Small Intestine...
Small Intestine...
Small Intestine...
Stage 0 Non-sma...
Stage I Adult S...
Stage I Colon C...
Stage I Gastric...
Stage I Non-sma...
Stage I Ovarian...
Stage I Ovarian...
Stage I Pancrea...
Stage I Rectal ...
Stage I Uterine...
Stage II Adult ...
Stage II Colon ...
Stage II Gastri...
Stage II Non-sm...
Stage II Ovaria...
Stage II Ovaria...
Stage II Pancre...
Stage II Rectal...
Stage II Uterin...
Stage III Adult...
Stage III Colon...
Stage III Gastr...
Stage III Ovari...
Stage III Ovari...
Stage III Pancr...
Stage III Recta...
Stage III Uteri...
Stage IIIA Non-...
Stage IIIB Non-...
Stage IV Adult ...
Stage IV Colon ...
Stage IV Gastri...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Rectal...
Stage IV Uterin...
Unresectable Ex...
Unresectable Ga...
EF5
motexafin lutet...
pharmacological...
18 Years - National Cancer Institute (NCI)
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive TractNCT00003334
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Sarcoma
paclitaxel
pegylated lipos...
- 120 YearsNYU Langone Health
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine LeiomyosarcomaNCT00101127
Sarcoma
filgrastim
pegfilgrastim
docetaxel
gemcitabine hyd...
18 Years - GOG Foundation
Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid TumorsNCT01155258
Extensive Stage...
Hereditary Para...
Male Breast Can...
Malignant Parag...
Metastatic Gast...
Metastatic Pheo...
Pancreatic Poly...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Gastr...
Recurrent Islet...
Recurrent Neuro...
Recurrent Non-s...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pheoc...
Recurrent Prost...
Recurrent Renal...
Recurrent Small...
Recurrent Uteri...
Regional Gastro...
Regional Pheoch...
Stage III Cervi...
Stage III Endom...
Stage III Neuro...
Stage III Ovari...
Stage III Ovari...
Stage III Prost...
Stage III Renal...
Stage III Uteri...
Stage IIIA Brea...
Stage IIIA Non-...
Stage IIIB Brea...
Stage IIIB Non-...
Stage IIIC Brea...
Stage IV Breast...
Stage IV Endome...
Stage IV Neuroe...
Stage IV Non-sm...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Prosta...
Stage IV Renal ...
Stage IV Uterin...
Stage IVA Cervi...
Stage IVB Cervi...
Thyroid Gland M...
temsirolimus
vinorelbine dit...
18 Years - University of Southern California
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaNCT00003939
Brain and Centr...
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
trabectedin
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic CancerNCT00032162
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Sarcoma
carboplatin
pegylated lipos...
18 Years - AGO Study Group
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaNCT00041236
Sarcoma
exatecan mesyla...
15 Years - 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Thalidomide in Treating Patients With Gynecologic SarcomasNCT00006005
Endometrial Can...
Sarcoma
thalidomide
- National Cancer Institute (NCI)
BI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsNCT00526149
Breast Cancer
Endometrial Can...
Head and Neck C...
Melanoma (Skin)
Ovarian Cancer
Sarcoma
BI 2536
high performanc...
mass spectromet...
pharmacological...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By SurgeryNCT01553539
Bone Cancer
Chondrosarcoma
Clear Cell Sarc...
Metastatic Oste...
Ovarian Sarcoma
Recurrent Adult...
Recurrent Osteo...
Recurrent Uteri...
Stage III Adult...
Stage III Uteri...
Stage IV Adult ...
Stage IV Uterin...
therapeutic ang...
laboratory biom...
18 Years - Wake Forest University Health Sciences
Combination Chemotherapy in Treating Patients With Endometrial Cancer, Fallopian Tube Cancer, or Sarcoma of the Female Reproductive TractNCT00003334
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Sarcoma
paclitaxel
pegylated lipos...
- 120 YearsNYU Langone Health
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaNCT00083213
Cancer
ziv-aflibercept
18 Years - 120 YearsRegeneron Pharmaceuticals
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the UterusNCT00033644
Sarcoma
sargramostim
cisplatin
dacarbazine
doxorubicin hyd...
mitomycin C
18 Years - GOG Foundation
Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable LeiomyosarcomaNCT00033709
Sarcoma
temozolomide
thalidomide
18 Years - National Cancer Institute (NCI)
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.NCT00258401
Cervical Cancer
Diarrhea
Prostate Cancer
Radiation Toxic...
Sarcoma
dietary interve...
management of t...
quality-of-life...
20 Years - 80 YearsCase Comprehensive Cancer Center
Low-Residue Diet in Treating Diarrhea in Patients Receiving Pelvic Radiation Therapy.NCT00258401
Cervical Cancer
Diarrhea
Prostate Cancer
Radiation Toxic...
Sarcoma
dietary interve...
management of t...
quality-of-life...
20 Years - 80 YearsCase Comprehensive Cancer Center
Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the UterusNCT00378911
Recurrent Uteri...
Uterine Leiomyo...
sunitinib malat...
18 Years - National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerNCT00003704
Cancer
capecitabine
radiation thera...
18 Years - Alliance for Clinical Trials in Oncology
Ecteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaNCT00003939
Brain and Centr...
Endometrial Can...
Gastrointestina...
Ovarian Cancer
Sarcoma
Small Intestine...
trabectedin
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for CancerNCT01132547
Cancer
cyproheptadine ...
placebo
2 Years - 21 YearsUniversity of South Florida
Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the UterusNCT01061606
Recurrent Uteri...
Uterine Carcino...
temsirolimus
18 Years - National Cancer Institute (NCI)
Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the UterusNCT00003316
Sarcoma
gemcitabine hyd...
18 Years - GOG Foundation
Surgery With or Without Chemotherapy in Treating Patients With Soft Tissue SarcomaNCT00002641
Endometrial Can...
Kidney Cancer
Ovarian Cancer
Pheochromocytom...
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
isolated perfus...
adjuvant therap...
conventional su...
radiation thera...
16 Years - 69 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Exatecan Mesylate in Treating Patients With Advanced Soft Tissue SarcomaNCT00041236
Sarcoma
exatecan mesyla...
15 Years - 75 YearsEuropean Organisation for Research and Treatment of Cancer - EORTC
Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue SarcomaNCT00004066
Ovarian Cancer
Sarcoma
Small Intestine...
filgrastim
docetaxel
gemcitabine hyd...
18 Years - Memorial Sloan Kettering Cancer Center
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue SarcomaNCT00410462
Ovarian Cancer
Sarcoma
Small Intestine...
brostallicin
doxorubicin hyd...
18 Years - European Organisation for Research and Treatment of Cancer - EORTC
Improving Employment in Patients Who Have Survived Cervical Cancer, Uterine Cancer, or Ovarian CancerNCT00383279
Cervical Cancer
Ovarian Cancer
Sarcoma
counseling inte...
study of socioe...
18 Years - 120 YearsWake Forest University Health Sciences
Chemotherapy in Treating Patients With Sarcoma of the UterusNCT00005643
Endometrial Can...
Sarcoma
pegylated lipos...
21 Years - GOG Foundation
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast CancerNCT01764789
Anxiety Disorde...
Depression
Fatigue
Leydig Cell Tum...
Ovarian Sarcoma
Ovarian Stromal...
Pain
Peritoneal Carc...
Pseudomyxoma Pe...
Recurrent Breas...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Gesta...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Recurrent Uteri...
Recurrent Vagin...
Recurrent Vulva...
questionnaire a...
quality-of-life...
psychosocial as...
behavioral inte...
cognitive inter...
educational int...
21 Years - 85 YearsOhio State University Comprehensive Cancer Center
Conformal Radiation Therapy in Treating Patients With Metastatic Cancer Outside the BrainNCT00550654
Kidney Cancer
Melanoma (Skin)
Metastatic Canc...
Ovarian Cancer
Sarcoma
Unspecified Adu...
questionnaire a...
3-dimensional c...
hypofractionate...
image-guided ra...
tomotherapy
18 Years - National Institutes of Health Clinical Center (CC)
PV701 in Treating Patients With Advanced or Recurrent Peritoneal CancerNCT00055705
Cancer
PV701
18 Years - National Cancer Institute (NCI)
Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal CavityNCT00003548
Cancer
aminocamptothec...
18 Years - NYU Langone Health
Paclitaxel and Carboplatin in Treating Patients With Persistent or Recurrent Stage III or Stage IV Uterine CancerNCT00112489
Sarcoma
carboplatin
paclitaxel
18 Years - 120 YearsGOG Foundation
Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the UterusNCT00003054
Sarcoma
paclitaxel
- 120 YearsGOG Foundation
Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue SarcomaNCT00002764
Endometrial Can...
Kidney Cancer
Metastatic Canc...
Ovarian Cancer
Pheochromocytom...
Sarcoma
filgrastim
doxorubicin hyd...
ifosfamide
conventional su...
16 Years - European Organisation for Research and Treatment of Cancer - EORTC
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological CancerNCT01652794
Leydig Cell Tum...
Ovarian Sarcoma
Ovarian Stromal...
Pseudomyxoma Pe...
Recurrent Cervi...
Recurrent Endom...
Recurrent Fallo...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Prima...
Recurrent Uteri...
Recurrent Vagin...
Recurrent Vulva...
stereotactic bo...
carboplatin
gemcitabine hyd...
laboratory biom...
pharmacogenomic...
19 Years - Case Comprehensive Cancer Center
Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue LeiomyosarcomaNCT00227669
Sarcoma
docetaxel
gemcitabine hyd...
18 Years - 120 YearsUNICANCER
Intravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaNCT00082823
Cancer
ziv-aflibercept
18 Years - 120 YearsRegeneron Pharmaceuticals
Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by SurgeryNCT00842452
Cervical Cancer
Endometrial Can...
Fallopian Tube ...
Ovarian Cancer
Sarcoma
Vaginal Cancer
Vulvar Cancer
topotecan hydro...
pharmacological...
18 Years - Case Comprehensive Cancer Center
Thalidomide in Treating Patients With Gynecologic SarcomasNCT00006005
Endometrial Can...
Sarcoma
thalidomide
- National Cancer Institute (NCI)
Chemotherapy Plus Radiation Therapy in Treating Patients With Unresectable, Residual, or Recurrent Colorectal CancerNCT00003704
Cancer
capecitabine
radiation thera...
18 Years - Alliance for Clinical Trials in Oncology
Imatinib Mesylate in Treating Patients With Recurrent or Persistent Uterine CancerNCT00075400
Recurrent Uteri...
Uterine Carcino...
imatinib mesyla...
laboratory biom...
- National Cancer Institute (NCI)
Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue SarcomaNCT00003778
Ovarian Cancer
Sarcoma
dolastatin 10
18 Years - National Cancer Institute (NCI)
Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Refractory Solid TumorsNCT00499291
Cancer
paclitaxel albu...
gene expression...
laboratory biom...
pharmacological...
polymerase chai...
18 Years - 120 YearsEastern Cooperative Oncology Group
Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the UterusNCT00033644
Sarcoma
sargramostim
cisplatin
dacarbazine
doxorubicin hyd...
mitomycin C
18 Years - GOG Foundation
Sorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent SarcomaNCT00245102
Adult Angiosarc...
Adult Epithelio...
Adult Leiomyosa...
Adult Malignant...
Adult Neurofibr...
Adult Synovial ...
Ovarian Sarcoma
Recurrent Adult...
Recurrent Uteri...
Stage III Adult...
Stage III Uteri...
Stage IV Adult ...
Stage IV Uterin...
Uterine Carcino...
Uterine Leiomyo...
sorafenib tosyl...
18 Years - National Cancer Institute (NCI)
Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: